September 2011 
Volume 41  Number 9
Pages 13 - 13
  PDF Version Available!

A booster vaccine has been approved to prevent tetanus, diphtheria, and pertussis in people age 65 and older. Boostrix, which is given as a single-dose booster injection, had already been approved for use in children and adults ages 10 through 64. It's the first single-dose vaccine approved to prevent all three diseases in older adults.A study involving 1,300 adults age 65 and older demonstrated the safety and effectiveness of Boostrix in older adults. The antibody levels among those given the booster were comparable to levels in infants who received a similar vaccine for pertussis prevention. The antibody resp-onses to the tetanus and diphtheria components were compared with a licensed tetanus and diphtheria vaccine and were found comparable. Common adverse -reactions reported by participants were headache, fatigue, and pain at the injection site.The incidence of pertussis has been increasing in the United States since 2007, with many outbreaks occurring among older patients in long-term-care

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events